FDA Should Rethink Its Definition Of A High-Risk Device, Say Patient Advocates
This article was originally published in The Gray Sheet
Executive Summary
Patient and consumer groups urged FDA to rethink its current stance on what constitutes a high-risk device at a meeting on the 510(k) program last week.
You may also be interested in...
FDA Panel: Transvaginal Mesh For Prolapse Should Be Class III
Current and future surgical mesh devices for pelvic organ prolapse repair would require PMA submissions under a recommendation last week by FDA’s Obstetrics and Gynecology Devices panel.
Institute Of Medicine On 510(k) Review Program: Dump It
The Institute of Medicine committee charged with reviewing FDA's 510(k) device pre-market review program is urging the agency to ditch the 35-year-old program and start fresh.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.